157 related articles for article (PubMed ID: 32894711)
1. Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by
Pan X; Phan TL; Adel M; Fossati C; Gaidon T; Wojak J; Guedj E
IEEE Trans Med Imaging; 2021 Jan; 40(1):81-92. PubMed ID: 32894711
[TBL] [Abstract][Full Text] [Related]
2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
[TBL] [Abstract][Full Text] [Related]
4. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
[TBL] [Abstract][Full Text] [Related]
5. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
[TBL] [Abstract][Full Text] [Related]
6. Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
Kishore N; Goel N
Neurosci Lett; 2023 Nov; 817():137530. PubMed ID: 37858874
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
8. Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study.
Teng L; Li Y; Zhao Y; Hu T; Zhang Z; Yao Z; Hu B;
BMC Neurol; 2020 Apr; 20(1):148. PubMed ID: 32316912
[TBL] [Abstract][Full Text] [Related]
9. Multi-scale discriminative regions analysis in FDG-PET imaging for early diagnosis of Alzheimer's disease.
Zhang J; He X; Qing L; Xu Y; Liu Y; Chen H
J Neural Eng; 2022 Aug; 19(4):. PubMed ID: 35882218
[No Abstract] [Full Text] [Related]
10. Distinct subtypes of spatial brain metabolism patterns in Alzheimer's disease identified by deep learning-based FDG PET clusters.
Ryoo HG; Choi H; Shi K; Rominger A; Lee DY; Lee DS;
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):443-454. PubMed ID: 37735259
[TBL] [Abstract][Full Text] [Related]
11. Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images.
Shen T; Jiang J; Lu J; Wang M; Zuo C; Yu Z; Yan Z
Mol Imaging; 2019; 18():1536012119877285. PubMed ID: 31552787
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
13. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
[TBL] [Abstract][Full Text] [Related]
14. Multi-Modality Sparse Representation for Alzheimer's Disease Classification.
Kwak K; Yun HJ; Park G; Lee JM;
J Alzheimers Dis; 2018; 65(3):807-817. PubMed ID: 29562503
[TBL] [Abstract][Full Text] [Related]
15. Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment.
Apostolova I; Lange C; Suppa P; Spies L; Klutmann S; Adam G; Grothe MJ; Buchert R;
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1417-1422. PubMed ID: 29502311
[TBL] [Abstract][Full Text] [Related]
16. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study.
Ou YN; Xu W; Li JQ; Guo Y; Cui M; Chen KL; Huang YY; Dong Q; Tan L; Yu JT;
Alzheimers Res Ther; 2019 Jun; 11(1):57. PubMed ID: 31253185
[TBL] [Abstract][Full Text] [Related]
18. Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on
Zhou P; Zeng R; Yu L; Feng Y; Chen C; Li F; Liu Y; Huang Y; Huang Z;
Front Aging Neurosci; 2021; 13():764872. PubMed ID: 34764864
[No Abstract] [Full Text] [Related]
19. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
[TBL] [Abstract][Full Text] [Related]
20. Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.
Wang M; Jiang J; Yan Z; Alberts I; Ge J; Zhang H; Zuo C; Yu J; Rominger A; Shi K;
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2753-2764. PubMed ID: 32318784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
